Cistanche
Best-in-class: Cistanche
A desert plant extract used for testosterone, libido, energy and (via its unique phenylethanoids) neuroprotection.
Cistanche quick facts
| Suggested dose | 300–1,000 mg standardized extract daily. |
| How often | Daily |
| Who it's for | Libido, testosterone, energy and brain support (men and women). |
Long traditional use, animal data on sexual function, and short thin human trials — a fair summary of the whole category. It is often marketed alongside claims about follicle-stimulating pathways that outrun what has been shown. Well tolerated. Worth treating as promising rather than established.
How Cistanche actually works
Echinacoside and acteoside are the characterized actives, with proposed effects on the HPG axis, erectile function via nitric oxide, and neuroprotection. Traditional Chinese use for kidney-yang deficiency corresponds roughly to what would now be described as low libido and fatigue.
Where to get Cistanche
Find Cistanche on iHerb →The evidence for Cistanche
Graded by what exists behind each claim.
✅ Clinically validated
- Studies show support for testosterone, sexual function and cognition; rich in echinacoside/acteoside.
- Traditionally a kidney/yang tonic for vitality.
📊 Correlative data
- Used in traditional Chinese medicine for centuries as a kidney-yang tonic for fatigue and sexual function, and known as 'desert ginseng'. Consistent traditional application; essentially no modern epidemiology.
🧪 Theoretical / extrapolated benefits
- Neuroprotective and 'longevity' claims are early — the libido/energy use is better established.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Cistanche actually does
Cistanche tubulosa is a root parasite of desert shrubs with no chlorophyll of its own, and the part harvested is the fleshy succulent stem — which is what the European regulatory dossier on it assesses: a water extract of Cistanche tubulosa stems EFSA NDA Panel 2021. Its characterized chemistry is a class of molecules called phenylethanoid glycosides, and two of them carry every claim on the label: echinacoside and acteoside (also written verbascoside).
The one named receptor in this whole file is the ghrelin receptor, and it is a good story. Echinacoside isolated from C. tubulosa activates the growth hormone secretagogue receptor 1a — GHS-R1a, the receptor ghrelin uses — and stimulates growth hormone secretion, with activity appearing at concentrations higher than 10−6 M Wu 2019. That is a specific G-protein-coupled receptor with a specific threshold, and it is a far better mechanism than ‘kidney yang tonic’. Write the threshold down: 1 micromolar. Everything else on this page is a question about whether a molecule of that size can reach it.
The reason to doubt that it can is written into the molecule. Echinacoside is a caffeoyl phenylethanoid carrying three sugars. That is a large, highly polar, hydrogen-bond-rich structure — the opposite of what crosses an enterocyte membrane by passive diffusion. Glycosides of this class are substrates for gut bacterial beta-glucosidases and rhamnosidases, which cleave the sugars in the colon; what then appears in blood is largely the small aglycone fragments — hydroxytyrosol and caffeic acid — and their sulfate and glucuronide conjugates, not the intact glycoside that activated the receptor in the dish.
The testosterone mechanism, stated at the honesty level it deserves. This product is bought mainly for androgens, and the steroidogenic work behind that is animal work. There is no step in the human literature on this page where a testosterone was drawn. The receptor that has been named Wu 2019 is a growth hormone receptor, not an androgen one, and if anything about cistanche eventually turns out to be real in people, GH is where the mechanism currently points.
Cell, rodent, human — and where it stops
The dish sets the number: above 1 µM, echinacoside activates GHS-R1a Wu 2019. Hold that against the absorption literature, which is unusually revealing because of what it is trying to do. The published pharmaceutical work on echinacoside is not about what it does — it is about getting it in. A phospholipid complex improved the intestinal absorption rate 2.82-fold and the effective permeability coefficient 3.39-fold Li 2015. A compound that needs a formulation rescue to triple its permeability is a compound whose unmodified form does not cross well, and a threefold rescue does not close a gap of the size a micromolar target usually implies.
Human trial one: 26 people and a p of 0.046. A placebo-controlled, randomized, double-blind study gave a Cistanche tubulosa Wight extract for 12 weeks to adults over 60 with locomotive syndrome; 26 subjects completed, and the reported significance was p = 0.046 Inada 2021. That is the entire single-herb randomized evidence base in humans. Twenty-six completers with a p-value a hair under the threshold is a result to note and not a result to buy on.
Human trial two is bigger, better and about a different product. One hundred middle-aged and elderly Chinese participants took two tablets daily for 90 days, each pair delivering 72 mg of echinacoside and 27 mg of flavonol glycosides — that second number is Ginkgo biloba. Against placebo, MMSE rose from 26.5 to 27.1 (p < 0.001), MoCA from 23.4 to 25.3 (p < 0.001) and the WHO quality-of-life score from 81.6 to 84.2 (p < 0.001), with improvements on the Wechsler Memory Scale-Revised; total tau and the phosphorylated tau species pT181, pS199, pT231 and pS396 fell, TSH fell, and triiodothyronine and free triiodothyronine rose Chen 2024. Real endpoints, real biomarkers, and nothing in it can be assigned to cistanche, because ginkgo was in every tablet.
The largest human exposure on record is in a safety dossier, not an efficacy trial. Assessing the water extract of the stems as a Novel Food, the European regulator worked from human data including 1,076 patients with vascular dementia taking 1,800 mg daily, among whom 12 adverse events were considered related to exposure and 2 of those were classified as severe EFSA NDA Panel 2021. That is the biggest number in this file and it is a tolerability number.
So the obstacle is a stack of three, and they compound. The receptor needs micromolar Wu 2019; the molecule needs help to cross a gut Li 2015; and the only two efficacy trials are a 26-person study Inada 2021 and a two-herb combination Chen 2024. None of the three is fatal on its own. Together they mean that the honest description of cistanche is ‘a plausible mechanism with a promising combination trial and no single-ingredient evidence worth the price’ — which is a different sentence from the one on most labels.
Cistanche — which form, and does it matter
Species and plant part, and both are printed wrong more often than not. The human trials and the regulatory dossier are all Cistanche tubulosa Inada 2021 Chen 2024 EFSA NDA Panel 2021, not C. deserticola, and the tissue is the stem EFSA NDA Panel 2021. A label reading “Cistanche root extract” is describing a tissue the evidence does not come from, on a plant whose above-ground succulent stem is the traditional and the studied material.
The number that matters is echinacoside milligrams, not extract milligrams. The cognitive trial delivered 72 mg of echinacoside per day Chen 2024. Do the arithmetic against a retail bottle: a 300 mg capsule standardized to 10% echinacoside supplies 30 mg, so matching the trial takes about 720 mg of a 10% extract — and you would still be taking it without the ginkgo that was in every tablet of that trial. An unstandardized extract, or one that states only a plant-to-extract ratio, cannot be compared with any of this at all.
Water extract is the version with the regulatory file behind it. The Novel Food assessment is of a water extract of the stems EFSA NDA Panel 2021. Ethanolic and hydroalcoholic extracts pull a different ratio of phenylethanoid glycosides to iridoids and lignans, and no human safety dossier covers them at the same intake.
What a formulation would have to fix, and what to be skeptical of. The one published route to more echinacoside in blood is a phospholipid complex, and it bought a threefold permeability gain Li 2015. A product claiming enhanced absorption should therefore say which complex, at what phospholipid ratio, with what measurement — and no retail cistanche does. Absent that, a ‘20:1 concentrated’ claim is a statement about how much plant went in, not about how much molecule comes out the other side.
What would have to be true, and how you would know it was not
1. The androgen panel, which is what it is sold for and which nobody has ever published. Draw total-testosterone and free-testosterone before and at eight weeks, both between 8 and 10 a.m. Predict both flat. This is not a hedge: there is no human testosterone measurement in the cistanche literature at all Inada 2021 Chen 2024 EFSA NDA Panel 2021, so a personal before-and-after is not confirming a trial, it is the only data that will ever exist about you.
2. igf-1 is the prediction that could vindicate the mechanism. If the ghrelin-receptor result transfers to a person, growth hormone is the output and IGF-1 is its stable, integrated, once-a-day-measurable proxy. Predict IGF-1 unchanged at eight weeks, because the receptor needed above 1 µM in a dish Wu 2019 and the molecule needs a formulation rescue to cross an intestine Li 2015. But note what a positive result would mean: an IGF-1 that genuinely rose would be the first evidence that this mechanism survives a human gut, and it would be worth writing up rather than celebrating quietly.
3. tsh and free-t4, because of a finding nobody is discussing. The 90-day combination trial reported TSH falling while T3 and free T3 rose Chen 2024. Whether that belongs to cistanche, to ginkgo or to chance in a single study, it is a thyroid signal in a supplement trial and it is the sort of thing that gets skipped. Draw TSH and free T4 at baseline and 12 weeks. Predict no change — and if TSH does move, that is a reason to stop and speak to somebody, particularly on levothyroxine.
4. Cognition, scored so the practice effect does not do the work. The trial's MoCA rose 1.9 points over 90 days on a two-herb tablet Chen 2024. On cistanche alone predict less than that, and note that MoCA improves on repeat administration regardless of treatment — so use an alternate form, or leave at least six months, or the second score is measuring familiarity.
5. Blood pressure, free and worth taking. Cistanche is reported to lower blood pressure. Take a week of home readings before starting and a week at eight weeks, same cuff, same arm, same time of day. Predict a fall of a few millimetres of mercury or none, and treat any larger fall as an interaction with whatever antihypertensive is already on board rather than as a benefit.
What nobody has tested yet
Nobody has drawn a testosterone. A plant sold across the English-speaking internet as a testosterone botanical has a human literature consisting of a locomotive-syndrome study, a combination cognition study and a safety dossier Inada 2021 Chen 2024 EFSA NDA Panel 2021, and not one of them measured the hormone. Forty men, eight weeks, one morning blood draw at each end: this is the least demanding missing study in the whole cohort.
Nobody has separated cistanche from ginkgo. The best cognitive result in this file was produced by a tablet containing both Chen 2024. A three-arm trial — cistanche, ginkgo, combination — is the obvious design, and until somebody runs it the tau and quality-of-life numbers belong to a product rather than to an ingredient.
Nobody has published what an ordinary capsule achieves in plasma. The absorption work exists to improve echinacoside's permeability Li 2015, so the baseline it improves on is documented only as the thing being improved. What concentration a person actually reaches after 300 mg of a standardized extract is unmeasured, and it is the single number that would settle whether the 1 µM receptor threshold Wu 2019 is reachable at all.
And nobody has looked at the thyroid signal twice. TSH down with T3 up appeared in one 90-day trial Chen 2024 and has not been replicated or explained. A supplement that moves thyroid indices is either doing something interesting or producing a statistical artifact, and both possibilities deserve a second study more than they deserve silence.
Cistanche — its own safety story, not its category's
The tolerability evidence here is better than the efficacy evidence, which is an unusual thing to be able to say. A European regulator assessing the water extract of the stems as a Novel Food worked from a human dataset of 1,076 vascular dementia patients at 1,800 mg daily, of whom 12 had adverse events considered related to the exposure and 2 of those were severe EFSA NDA Panel 2021. Most botanicals on this shelf have no comparable file. That is a real point in cistanche's favor and it should be weighed as one.
The thyroid finding is this product's own risk story, not the category's. TSH fell and T3 and free T3 rose over 90 days in the combination trial Chen 2024. Nobody has explained it and nobody has replicated it. Anyone on levothyroxine, carbimazole or methimazole, or with Hashimoto's or Graves' disease, is taking something with an unreplicated thyroid signal, and the sensible response is a TSH before and a TSH twelve weeks later rather than avoidance.
The mechanism-level caution follows the receptor. If echinacoside genuinely activates GHS-R1a in a person Wu 2019, then it is behaving like a ghrelin-receptor agonist — and that class raises appetite and can raise glucose acutely. This has never been demonstrated in a human taking cistanche, and it is written here as a mechanism to watch rather than a documented effect: anyone with diabetes who is measuring anyway has no reason not to look.
Blood pressure, and pregnancy, and one sourcing note. A reported hypotensive tendency is additive with antihypertensive drugs and with anything else on the shelf doing the same. Pregnancy has no data and cistanche is traditionally used partly for its bowel-moistening action, which is a laxative effect by another name; that is not a combination to experiment with while pregnant. And because the plant is a wild desert parasite under cultivation pressure, species substitution is a genuine commercial problem — a product that does not name C. tubulosa and the stem EFSA NDA Panel 2021 has not told you what is in it.
Sources read for this page
- Inada Y, et al. Effects of Cistanche tubulosa Wight Extract on Locomotive Syndrome: A Placebo-Controlled, Randomized, Double-Blind Study. Nutrients 2021 · PMID 33477648
- Chen L, et al. A randomized, double-blind, placebo-controlled study of Cistanche tubulosa and Ginkgo biloba extracts for the improvement of cognitive function in middle-aged and elderly people. Phytotherapy Research 2024 · PMID 38972848
- Wu CJ, et al. Echinacoside Isolated from Cistanche tubulosa Putatively Stimulates Growth Hormone Secretion via Activation of the Ghrelin Receptor. Molecules 2019 · PMID 30781558
- EFSA NDA Panel. Safety of water extract of Cistanche tubulosa stems as a Novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal 2021 · PMID 33488809
- Li F, et al. Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Drug Development and Industrial Pharmacy 2015 · PMID 25686726
How you would know if it worked
The testosterone claim rests on small studies that have not been widely replicated, which is exactly the situation a personal before-and-after is good for. Draw total and free testosterone before starting and again after eight weeks on the same dose — and both times between 8 and 10 a.m., because testosterone falls across the day and a late draw compared against an early one will manufacture a decline that never happened. The honest prior is that most botanicals sold for testosterone do not move it in trials, so a flat result is the common one. It does not sink the libido and energy claims, which are scored on how you feel rather than on this number, but it does settle the one claim on the label that a lab can settle.
- Total Testosterone Retest: 6–8 weeks after any protocol change; every 3–6 months on TRT.
- Free Testosterone Retest: With every total T retest — they must be interpreted together.
Draw before you start, not after. A result with nothing to compare it to answers nothing.
Cistanche — safety & side effects
- Well tolerated in the available data; mild GI upset is the main report.
- Long-term safety has not been characterized — the trials run weeks to months, not years. That is a real limit on what anyone can tell you about daily use for a decade. Most of the safety record is traditional use rather than trials.
- May lower blood pressure. Avoid in pregnancy.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Cistanche in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Cistanche
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| TSH (Thyroid-Stimulating Hormone) | Thyroid sits upstream of most things labeled 'hormonal' |
| Free T4 (Thyroxine) | Distinguishes a real thyroid problem from a borderline TSH |
| Total Testosterone | The baseline, if any of this is aimed at androgens |
| Vitamin D (25-Hydroxy) | Behaves like a hormone and is commonly low |
The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.
Check results you already have → · All 103 markers A–Z
Cistanche — frequently asked questions
What is Cistanche?
A desert plant extract used for testosterone, libido, energy and (via its unique phenylethanoids) neuroprotection.
What is the suggested dose of Cistanche?
300–1,000 mg standardized extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Cistanche dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Cistanche?
Coach Cam sources Cistanche from vetted, top-rated brands on iHerb — use the buy link on this page.
Cistanche inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Cistanche is used for
Cistanche appears under 3 goals in the goal router.
Related Hormonal & Wellness supplements
Where this goes next
Cistanche is the upstream arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.